Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-975-2 | CAS number: 112-47-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June to October 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Version / remarks:
- 1981
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Hexane-1,6-diol
- EC Number:
- 211-074-0
- EC Name:
- Hexane-1,6-diol
- Cas Number:
- 629-11-8
- Molecular formula:
- C6H14O2
- IUPAC Name:
- hexane-1,6-diol
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr Karl Thomae GmbH, Biberach/Riss, FRG
- Age at study initiation: 42 day old
- Weight at study initiation: 183 g (males), 147 g (females)
- Fasting period before sacrifice
- Housing: singly
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 8 days
DETAILS OF FOOD AND WATER QUALITY:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24 °C
- Humidity (%): 30-70%
- Air changes (per hr): "fully air-conditioned room"
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Details on route of administration:
- Volume of administration: 10 ml/kg bw
- Vehicle:
- water
- Details on oral exposure:
- The test substance was administered as a solution in doubly distilled water.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Investigations to characterize the test substance in respect of purity and homogeneity were carried out before the start if the study.
The stability of the test substance over a period of 17 months was proven. Due ti the short study duration a reanalysis after the experiemental phase of the study was not considered to be necessary.
The preparations were not stored for longer than 4 hours.
At the start of the study, one sample of each concentration was sent to the analytical laboratory for determination of the correctness of the concentration of the test preparations. - Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 400 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: based on acute data
- Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes, twice a day (one day on Saturdays and Sundays)
DETAILED CLINICAL OBSERVATIONS: Yes, once week
BODY WEIGHT: Yes at day 0, then weekly
FOOD CONSUMPTION : yes, weekly
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: at the end of the styudy, in the morning from non-fasted
- Anaesthetic used for blood collection: no data
- Animals fasted: Yes
- How many animals: 5 animals/group
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood:t the end of the styudy, in the morning from non-fasted
- Animals fasted: Yes
- How many animals: 5 animals/group
URINALYSIS: Yes
- Time schedule for collection of urine: at the end of the study
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Yes
- How many animals: 5 animals/group
NEUROBEHAVIOURAL EXAMINATION: no
IMMUNOLOGY: no - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes - Other examinations:
- no
- Statistics:
- The data were evaluated statistically on the computer systems of the Department of Toxicology of BASF Aktiengesellschaft.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No signs attributable to the applications of the test substance were observed throughout the study period, with the exception of animal No . 19 (dose group 3 - 1000 mg/kg body weight/day), which showed paresis in both hindlimbs from day 17 to the end of the study.
Due to the isolated nature of the finding, it has to be regarded as an incidental one without being substance-related . - Mortality:
- no mortality observed
- Description (incidence):
- No animal died during the course of the study.
- Body weight and weight changes:
- effects observed, non-treatment-related
- Description (incidence and severity):
- The slightly decreased body weight (6% lower than the concurrent control value) and the slight depression in body weight gain (about 13 % lower than the concurrent control value) of the high dose males at the end of the study have to be seen in context with the slightly reduced food consumption mentioned before. It is likely that these observations were mainly caused by animal No.19. Therefore, they are not regarded as substance-related effects.
In the female animals of dose groups 1- 3 (100, 400 and 1000 mg/kg) slight to moderate decreases in body weight and body weight gain were found. These findings are considered to be of spontaneous nature because a clear dose-response relationship is missing. This includes also the statistically significantly lower mean body weight of female animals of the 400 mg/kg dose group on study day 28 (about 13 % lower than the concurrent control group values) and the statistically significantly diminished body weight gain of the 400 and 1000 mg/kg dose group females (about 31 % and 25 % lower when compared with the concurrent control group values) at the end of the study.
Body weight and body weight gain developed in dependence on the the respective food consumption values of the dosed and the control animals . Consequently these values were lower than the concurrent control values.
However, the body weight values of the dosed animals are fully in the range of the historical control data. Thus, the observations made for body weight and body weight gain are not regarded as substance related effects. - Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- Food consumption values of the male animals of dose group 3 (1 000 mg/kg body weight) and female animals of dose groups 1 - 3 (100 ; 400 ; 1000 mg/kg body weight) were slightly decreased during the course of the study when compared with the concurrent control values.
The food consumption value of the high dose males on study day 21 was about 8 % lower than the corresponding control value. This finding is probably related to the clear reduction of food consumption in animal No. 19. This animal showed paresis of both hindlimbs from study day 17 to the end of the study. Therefore, the finding of marginally decreased food consumption values of the high dose male animals is regarded to be incidental and not related to the test substance administered .
The reduced food consumption values of female animals of dose groups 1 - 3 are regarded as being of spontaneous nature due to the missing dose-response relationship. Moreover, all food consumption values of the dosed females are fully in the range of the historical control data, whereas the respective values of the concurrent control group are at the upper level of the historical control range.
Thus, the reduced food consumption values of female animals of dose groups 1- 3 in comparison to the concurrent control group values are regarded as being of spontaneous nature and not related to the test substance administration. - Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No treatment-related changes were observed in the results of hematology examinations of both sexes.
No treatment-related changes were observed in the results of the clotting analyses of both sexes.
There is only one statistically significant intergroup
difference in the results of clinical pathology
testing (Table 009 ; males ; test group 2 ; HCT) . This
finding is considered to be of no toxicological
concern, because it is sporadic, inconsistent, when
compared with the other sex, and lacks dose-response
relationship . - Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- No treatment-related changes were observed in the results of the serum enzyme examinations of both sexes .
No treatment-related changes were observed in the results of blood chemistry examinations of both sexes.
There is only one statistically significant intergroup difference in the results of clinical pathology testing (test group 2 ; HCT) . This finding is considered to be of no toxicological concern, because it is sporadic, inconsistent, when compared with the other sex, and lacks dose-response relationship . - Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- No treatment-related changes were observed in the results of the urinalyses of both sexes.
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- No substance-related findings were obtained at pathology.
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- not examined
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Target system / organ toxicity
- Critical effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this 4-week toxicity study, the oral administration (by gavage) of 1,6-hexanediol in dose levels of 100, 400 and 1,000 mg/kg bw/d to Wistar rats caused no substance-related effects .
- Executive summary:
1,6 -hexanediol was administered daily to groups of 5 male and 5 female Wistar rats per dose group by gavage as aqueous solution at doses of 0 (vehicle control), 100, 400 and 1000 mg/kg bw/day for 4 weeks. Vehicle was doubly distilled water.
Food consumption and body weight were determined. The state of health was checked each day. During the weekly waighing the animals were subjected to an additional comprehensive clinical examination. Clinicochemical and hematological examinations and urinalyses were carried out towards the end of the administration period. All animals were assessed by gross pathology, followed by histopathological examinations.
There were no substantial substance-related effects concerning food consumption, body weight, body weight change, clinical, clinicochemical, gross pathological and histopathological observations.
The observed statistical significances for the values of body weight and body weight change towards the end of the study in female rats are regarded as incidental, because of missing dose-response relationship. Furthermore, all of them are lying fully in the range of historical controls and are compared to relatively high values of the concurrent controls. Thus, The observed statistical significances for the values of body weight and body weight change towards the end of the study in female rats are regarded as incidental, because of missing dose-response relationship . Furthermore, all of them are lying fully in the range of historical controls and are compared to relatively high values of the concurrent controls. Under the conditions of this 4-week toxicity study, the oral administration (by gavage) of 1,6-hexanediol in dose levels of 100, 400 and 1,000 mg/kg bw/d to Wistar rats caused no substance-related effects .
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.